The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes
Open accessAbstract
Glucocorticoids (GCs) are broadly prescribed for numerous pathological conditions because of their anti-inflammatory, antiallergic and immunosuppressive effects, among other actions. Nevertheless, GCs can produce undesired diabetogenic side effects through interactions with the regulation of glucose homeostasis. Under conditions of excess and/or long-term treatment, GCs can induce peripheral insulin resistance (IR) by impairing insulin signalling, which results in reduced glucose disposal and augmented endogenous glucose production. In addition, GCs can promote abdominal obesity, elevate plasma fatty acids and triglycerides, and suppress osteocalcin synthesis in bone tissue. In response to GC-induced peripheral IR and in an attempt to maintain normoglycaemia, pancreatic β-cells undergo several morphofunctional adaptations that result in hyperinsulinaemia. Failure of β-cells to compensate for this situation favours glucose homeostasis disruption, which can result in hyperglycaemia, particularly in susceptible individuals. GC treatment does not only alter pancreatic β-cell function but also affect them by their actions that can lead to hyperglucagonaemia, further contributing to glucose homeostasis imbalance and hyperglycaemia. In addition, the release of other islet hormones, such as somatostatin, amylin and ghrelin, is also affected by GC administration. These undesired GC actions merit further consideration for the design of improved GC therapies without diabetogenic effects. In summary, in this review, we consider the implication of GC treatment on peripheral IR, islet function and glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Endocrine regulation of energy metabolism by the skeleton
Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.047 · Cited by 2,554
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
Ferron, M., Hinoi, E., Karsenty, G., & Ducy, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711119105 · Cited by 900
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696
Ghrelin Modulates Brain Activity in Areas that Control Appetitive Behavior
Malik, S., McGlone, F., Bedrossian, D., & Dagher, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.007 · Cited by 677
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Anagnostis, P. G., Athyros, V. G., Τζιόμαλος, Κ., Karagiannis, A. I., & Mikhailidis, D. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0370 · Cited by 625
Genomic and nongenomic effects of glucocorticoids
Stahn, C., & Buttgereit, F. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0898 · Cited by 594
Research works printed but not linked: 18
- 1984, American Journal of Physiology -- Legacy Content, 247, E592
- Brown, 1993, Endocrinology, 132, 2614, 10.1210/en.132.6.2614 · DOI · Paper page
- Hoes, 2010, Clinical and experimental rheumatology, 28, 354
- 1992, American Journal of Physiology -- Legacy Content, 263, E663
- 2014, Endocrinology, 27, 48
- 2011, MODERN RHEUMATOLOGY, 21, 495, 10.3109/s10165-011-0433-8 · DOI
- 1994, JOURNAL OF CLINICAL ENDOCRINOLOGY, 79, 820
- 1994, JOURNAL OF CLINICAL ENDOCRINOLOGY, 78, 1354
- 1993, American Journal of Physiology -- Legacy Content, 265, E446
- 1993, JOURNAL OF CLINICAL ENDOCRINOLOGY, 77, 1180
- 1998, American Journal of Physiology -- Legacy Content, 275, E806
- 1994, Journal of liposome research, 35, 1535
- 2008, NATURE CLINICAL PRACTICE RHEUMATOLOGY, 4, 525
- 1990, American Journal of Physiology -- Legacy Content, 258, E748
- T uber, 1984, International journal of clinical pharmacology, therapy, and toxicology, 22, 48
- 1990, American Journal of Physiology -- Legacy Content, 259, E626
- 1992, PNAS, 89, 35
- 2013, Journal of Molecular Endocrinology, 19, R35
Cited by
Sorted by citations
The crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 675
Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions
Li, J.-X., & Cummins, C. L. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00683-6 · Cited by 285
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
Sabir, S., Akash, M. S. H., Fiayyaz, F., Saleem, U., Mehmood, M. H., & Rehman, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108802 · Cited by 165
Glucocorticoid Signaling: An Update from a Genomic Perspective
Sacta, M. A., Chinenov, Y. V., & Rogatsky, I. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105323 · Cited by 155
Glucocorticoid-Induced Fatty Liver Disease
Rahimi, L., Rajpal, A., & Ismail‐Beigi, F. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s247379 · Cited by 151
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140
Transcriptomic responses to heat stress in rainbow trout Oncorhynchus mykiss head kidney
Huang, J., Li, Y., Liu, Z., Kang, Y., & Wang, J. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.08.002 · Cited by 129
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity
INSERM, U., & Fromenty, B. (2017) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.2017s1.006 · Cited by 124
Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications
Barbot, M., Zilio, M., & Scaroni, C. M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101380 · Cited by 126
Insulin Resistance: The Increased Risk of Cancers
Szablewski, L. (2024) · Current Oncology · doi:10.3390/curroncol31020075 · Cited by 123
KAMBA, A., Daimon, M., Murakami, H., Otaka, H., Matsuki, K., Sato, E., Tanabe, J., Takayasu, S., Matsuhashi, Y., Yanagimachi, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166077 · Cited by 107
Drug-induced liver injury in obesity and nonalcoholic fatty liver disease
Allard, J., Guillou, D. L., Begriche, K., & Fromenty, B. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.01.003 · Cited by 98
Metabolomics Based Profiling of Dexamethasone Side Effects in Rats
Malkawi, A. K., Alzoubi, K. H., Jacob, M., Matic, G., Ali, A., Faraj, A. A., Al-Mohanna, F., Dasouki, M., & Rahman, A. M. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00046 · Cited by 95
Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence
Pasieka, A. M., & Rafacho, A. (2016) · Metabolites · doi:10.3390/metabo6030024 · Cited by 91
Panic Disorder Comorbidity with Medical Conditions and Treatment Implications
Meuret, A. E., Kroll, J. L., & Ritz, T. (2017) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-021815-093044 · Cited by 90
Borujeni, M. J. S., Esfandiary, E., Baradaran, A., Valiani, A., Ghanadian, M., Codoñer‐Franch, P., Basirat, R., Alonso‐Iglesias, E., Mirzaei, H., & Yazdani, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27755 · Cited by 87
Jeong, Y., Han, H. S., Lee, H. D., Yang, J., Jeong, J., Choi, M. K., Kwon, J., Jeon, H., Oh, T., Lee, K. H., et al. (2016) · Cancer Research and Treatment · doi:10.4143/crt.2015.464 · Cited by 81
Hoffman, E. P., Riddle, V., Siegler, M. A., Dickerson, D., Bačkonja, M., Kramer, W. G., Nagaraju, K., Gordish‐Dressman, H., Damsker, J. M., & McCall, J. M. (2018) · Steroids · doi:10.1016/j.steroids.2018.02.010 · Cited by 77
The Metabolic Syndrome, a Human Disease
Alemany, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042251 · Cited by 86
Consensus on the key characteristics of metabolism disruptors
Merrill, M. A. L., Smith, M. T., McHale, C. M., Heindel, J. J., Atlas, E., Cave, M. C., Collier, D. N., Guyton, K. Z., Koliwad, S. K., Nadal, Á., et al. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01059-8 · Cited by 73
Huang, Z., Ma, A., Yang, S., Liu, X., Zhao, T., Zhang, J., Wang, X., Sun, Z., Liu, Z., & Xu, R. (2019) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2019.100632 · Cited by 66
Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA
Esguerra, J. L. S., Ofori, J. K., Nagao, M., Shuto, Y., Karagiannopoulos, A., Fadista, J., Sugihara, H., Groop, L., & Eliasson, L. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.12.012 · Cited by 64
Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?
Mayayo-Peralta, I., Zwart, W., & Preković, S. (2021) · Endocrine-Related Cancer · doi:10.1530/erc-20-0489 · Cited by 53
Glucocorticoid-Induced Hyperglycemia: A Neglected Problem
Cho, J.-H., & Suh, S. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1951 · Cited by 63
Androgens sensitise mice to glucocorticoid-induced insulin resistance and fat accumulation
Gasparini, S. J., Swarbrick, M. M., Kim, S., Thai, L. J., Henneicke, H., Cavanagh, L. L., Tu, J., Weber, M.-C., Zhou, H., & Seibel, M. J. (2019) · Diabetologia · doi:10.1007/s00125-019-4887-0 · Cited by 64
Metformin prevents metabolic side effects during systemic glucocorticoid treatment
Seelig, E., Meyer, S., Timper, K., Nigro, N., Bally, M. R., Pernicova, I., Schüetz, P., Müller, B., Korbonits, M., & Christ‐Crain, M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0653 · Cited by 59
Torres, R. M., Souza, M. D. S., Coelho, A. C. C., de Mello, L. M., & Souza‐Machado, C. (2021) · Canadian Respiratory Journal · doi:10.1155/2021/8830439 · Cited by 52
Sequeira, I. R., & Poppitt, S. D. (2017) · Nutrients · doi:10.3390/nu9070788 · Cited by 51
Protzek, A. O. P., de Rezende, L. F., Costa-Júnior, J. M., Ferreira, S. M., Cappelli, A. P. G., de Paula, F. M. M., de Souza, J. C., Kurauti, M. A., Carneiro, E. M., Rafacho, A., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.09.020 · Cited by 50
Coelho, P. G., Pippenger, B. E., Tovar, N., Koopmans, S. J., Plana, N. M., Graves, D. T., Engebretson, S. P., van Beusekom, H. M. M., de Oliveira, P. G. F. P., & Dard, M. M. (2018) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2018.02.021 · Cited by 52
Yu, I. S., & Cheung, W. Y. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/9450754 · Cited by 47
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 53
Cardiovascular and metabolic risk factors in patients with subclinical Cushing
Petramala, L., Olmati, F., Concistrè, A., Russo, R., Mezzadri, M., Soldini, M., Vincentis, G. D., Iannucci, G., Toma, G. D., & Letizia, C. (2020) · Endocrine · doi:10.1007/s12020-020-02297-2 · Cited by 50
Ellwood, R. A., Hewitt, J. E., Torregrossa, R., Philp, A. M., Hardee, J. P., Hughes, S., van de Klashorst, D., Gharahdaghi, N., Anupom, T., Slade, L., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018342118 · Cited by 43
Glucocorticoids, bone and energy metabolism
Cooper, M. S., Seibel, M. J., & Zhou, H. (2015) · Bone · doi:10.1016/j.bone.2015.05.038 · Cited by 48
The long winding road to the safer glucocorticoid receptor (GR) targeting therapies
Lesovaya, E. A., Chudakova, D. A., Baida, G. E., Михайловна, Ж. Е., Игоревич, К. К., Геннадиевна, Я. М., & Budunova, I. V. (2022) · Oncotarget · doi:10.18632/oncotarget.28191 · Cited by 43
Courty, É., Besseiche, A., Do, T. T. H., Liboz, A., Aguid, F. M., Quilichini, E., Buscato, M., Gourdy, P., Gautier, J., Riveline, J., et al. (2018) · Diabetes · doi:10.2337/db17-1314 · Cited by 41
Briffa, J. F., Hosseini, S., Tran, M., Moritz, K. M., Cuffe, J. S. M., & Wlodek, M. E. (2017) · Placenta · doi:10.1016/j.placenta.2017.09.006 · Cited by 40
Perinatal programming of metabolic diseases: The role of glucocorticoids
Facchi, J. C., de Lima, T. A. L., de Oliveira, L. R., Costermani, H. D. O., Miranda, G. D. S., & de Oliveira, J. C. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154047 · Cited by 38
Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?
Bavaresco, A., Mazzeo, P., Lazzara, M., & Barbot, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116137 · Cited by 41
Relationship Between Glucocorticoids and Insulin Resistance in Healthy Individuals
Zhou, P.-Z., Zhu, Y., Zou, G.-H., Sun, Y., Xiu, X., Huang, X. Y., & Zhang, Q. (2016) · Medical Science Monitor · doi:10.12659/msm.895251 · Cited by 35
Li, Z., Liu, Z., Wang, Y. N., Kang, Y. J., Wang, J. F., Shi, H. N., Huang, J., & Jiang, L. (2016) · Biologia · doi:10.1515/biolog-2016-0013 · Cited by 34
Lanzillotta, M., Tacelli, M., Falconi, M., Arcidiacono, P. G., Capurso, G., & Della‐Torre, E. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.03.014 · Cited by 34
Development of Metabolic Syndrome Associated to Cancer Therapy: Review
Casco, S., & Soto-Vega, E. N. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0274-1 · Cited by 34
Man, S., Ma, J., Yao, J., Cui, J., Wang, C., Li, Y., Ma, L., & Lu, F. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02206 · Cited by 35
Chruvattil, R., Banerjee, S., Nath, S., Machhi, J., Kharkwal, G. B., Yadav, M. R., & Gupta, S. S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0251-2 · Cited by 33
Sucrose consumption alters steroid and dopamine signalling in the female rat brain
Tobiansky, D. J., Kachkovski, G. V., Enos, R. T., Schmidt, K. L., Murphy, E. A., & Soma, K. K. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0386 · Cited by 32
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
Guarnotta, V., Stefano, C. D., Santoro, A., Ciresi, A., Coppola, A., & Giordano, C. S. D. S. (2019) · Endocrine Connections · doi:10.1530/ec-19-0176 · Cited by 32
Burke, S. J., Batdorf, H. M., Eder, A. E., Karlstad, M. D., Burk, D. H., Noland, R. C., Floyd, Z. E., & Collier, J. J. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.11.009 · Cited by 30
Guarnotta, V., Ciresi, A., Pillitteri, G., & Giordano, C. S. D. S. (2018) · Clinical Endocrinology · doi:10.1111/cen.13554 · Cited by 30
Koorneef, L. L., van der Meulen, M., Kooijman, S., Sánchez-López, E., Scheerstra, J. F., Voorhoeve, M. C., Ramesh, A. N. N., Rensen, P. C. N., Giera, M. A., Kroon, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.960279 · Cited by 31
Mo, Z., Li, L., Hai-wen, Y., Wu, Y., & Li, H. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.01.001 · Cited by 29
The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity
Koorneef, L. L., Kroon, J., Viho, E. M. G., Wahl, L. F., Heckmans, K. M. L., van Dorst, M. M. A. R., Hoekstra, M., Houtman, R., Hunt, H., & Meijer, O. C. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0486 · Cited by 29
HPA axis and vagus nervous function are involved in impaired insulin secretion of MSG-obese rats
Miranda, R. A., Torrezan, R., de Oliveira, J. C., Barella, L. F., Franco, C. C. D. S., Lisboa, P. C., de Moura, E. G., & Mathias, P. C. D. F. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0467 · Cited by 28
Ryu, K., Fukutomi, Y., Nakatani, E., Iwata, M., Nagayama, K., Yano, K., Nakamura, Y., Hamada, Y., Watai, K., Kamide, Y., et al. (2022) · Allergology International · doi:10.1016/j.alit.2022.10.005 · Cited by 27
Takikawa, T., Kikuta, K., Sano, T., Ikeura, T., Fujimori, N., Umemura, T., Naitoh, I., Nakase, H., Isayama, H., Kanno, A., et al. (2024) · Pancreatology · doi:10.1016/j.pan.2024.01.008 · Cited by 26
Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients
Boloori, A., Saghafian, S., Chakkera, H. A., & Cook, C. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142363 · Cited by 23
Ukraintseva, Y. V., Liaukovich, K. M., Saltykov, K. A., Belov, D. A., & Nizhnik, A. N. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.11.1254 · Cited by 25
Thomson, E. M., Pilon, S., Guénette, J., Williams, A., & Holloway, A. C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.01.020 · Cited by 24
Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?
Graziadio, C., Hasenmajer, V., Venneri, M. A., Gianfrilli, D., Isidori, A. M., & Sbardella, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00434 · Cited by 25
Specialised lipid mediators and their targets
Crean, D., & Godson, C. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.05.002 · Cited by 25
Товчига, О. В. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1221-y · Cited by 23
Targeting pancreatic beta cell death in type 2 diabetes by polyphenols
García-Aguilar, A., & Guillén, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1052317 · Cited by 26
Chronic hypercortisolism causes more persistent visceral adiposity than HFD-induced obesity
García-Eguren, G., Giró, O., Romero, M. D. M., Grasa, M., & Hanzu, F. A. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0168 · Cited by 27
Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine
Nagata, M., Nakajima, M., Ishiwata, Y., Takahashi, Y., Takahashi, H., Negishi, K., & Yasuhara, M. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00842 · Cited by 23
Zheng, X., Bi, W., Yang, G., Zhao, J., Wang, J., Li, X., & Zhou, X. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00983 · Cited by 20
Nutritional Mechanisms of Cancer Cachexia
Compton, S. L. E., Heymsfield, S. B., & Brown, J. C. (2024) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062122-015646 · Cited by 23
Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment
Gojani, E. G., Rai, S., Norouzkhani, F., Shujat, S., Wang, B., Li, D., Kovalchuk, O., & Kovalchuk, I. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070453 · Cited by 23
Sadhu, A., Schwartz, S. S., & Herman, M. E. (2015) · Endocrine Practice · doi:10.4158/ep14569.ra · Cited by 21
G6PC2 Modulates Fasting Blood Glucose In Male Mice in Response to Stress
Boortz, K. A., Syring, K. E., Dai, C., Pound, L. D., Oeser, J. K., Jacobson, D. A., Wang, J.-C., McGuinness, O. P., Powers, A. C., & O’Brien, R. M. (2016) · Endocrinology · doi:10.1210/en.2016-1245 · Cited by 20
Peng, Y., Zhong, S.-M., Yu-Hua, Q., Hui-Dan, X., & Wu-Jun, W. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/63023 · Cited by 21
Perioperative Glycemic Management in Cardiac Surgery: A Narrative Review
Thongsuk, Y., & Hwang, N. C. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.08.149 · Cited by 20
Marchi, D., & van Eeden, F. J. M. (2021) · Cells · doi:10.3390/cells10123441 · Cited by 21
Pathophysiology of Prediabetes, Diabetes, and Diabetic Remission in Cats
Gostelow, R., & Hazuchova, K. (2023) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2023.02.001 · Cited by 22
Sustained-Release Steroids for the Treatment of Diabetic Macular Edema
Daruich, A., Matet, A., & Béhar‐Cohen, F. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0669-3 · Cited by 20
Bönisch, C., Irmler, M., Brachthäuser, L., Neff, F., Bamberger, M. T., Marschall, S., de Angelis, M. H., & Beckers, J. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9616-5 · Cited by 22
G6PC2 Modulates the Effects of Dexamethasone on Fasting Blood Glucose and Glucose Tolerance
Boortz, K. A., Syring, K. E., Lee, R. A., Dai, C., Oeser, J. K., McGuinness, O. P., Wang, J.-C., & O’Brien, R. M. (2016) · Endocrinology · doi:10.1210/en.2016-1678 · Cited by 23
Gregoriou, K., Craigie, I., Gibson, B. E. S., Mason, A., & Shaikh, M. G. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.28085 · Cited by 20
Tao, N., Ge, H., Wu, W., An, H., Liu, J., & Xu, X. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0688-4 · Cited by 20
Erfidan, S., Dede, S., Usta, A., Yüksek, V., & Çetin, S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07479-x · Cited by 19
The Centrality of Obesity in the Course of Severe COVID-19
Liu, D., Zhang, T., Wang, Y., & Xia, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.620566 · Cited by 22
Kwok, H., Poon, P.-Y., Mak, K. H.-M., Zhang, L.-Y., Liu, P., Zhang, H., Mak, N. K., Yue, P. Y., & Wong, R. N. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2540-y · Cited by 19
Insulin Resistance in Congenital Adrenal Hyperplasia is Compensated for by Reduced Insulin Clearance
de Oliveira, D. M., Tura, A., Vasques, A. C. J., Camilo, D. F., Lima, M. M. D. O., de Lemos‐Marini, S. H. V., Gonçalves, E. M., Guerra‐Júnior, G., & Geloneze, B. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab010 · Cited by 18
Harno, E., Sefton, C., Wray, J. R., Allen, T.-J., Davies, A., Coll, A. P., & White, A. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-93378-3 · Cited by 18
Rigal, S., Casas, B., Kanebratt, K. P., Huldt, C. W., Magnusson, L. U., Müllers, E., Karlsson, F. H., Clausen, M., Hansson, S., Leonard, L., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06514-w · Cited by 22
Battiston, F. G., dos Santos, C., Barbosa, A. M., Sehnem, S., Leonel, E. C. R., Taboga, S. R., Anselmo-Franci, J. A., Lima, F. B., & Rafacho, A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.001 · Cited by 17
Nicolas, S., Rochet, N., Gautier, N., Chabry, J., & Pisani, D. F. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154027 · Cited by 17
Quagliarini, F., Makris, K., Friano, M. E., & Uhlenhaut, N. H. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad048 · Cited by 19
Long-term adjustment of hepatic lipid metabolism after chronic stress and the role of FGF21
Dille, M. A., Nikolic, A., Wahlers, N., Fahlbusch, P., Jacob, S., Hartwig, S., Lehr, S., Kabra, D. G., Klymenko, O., Al‐Hasani, H., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166286 · Cited by 16
Tong, X., Yang, L., Jiang, C., Weng, Z., Zu, A., Hou, Y., Fang, Y., Yang, W., & Sun, S. (2023) · Reproductive Sciences · doi:10.1007/s43032-022-00904-3 · Cited by 16
Zhang, X., Yan, Y., Zhang, F., Zhang, X., Xu, H., Liu, Y., & Huang, Y. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105496 · Cited by 16
Caduff, A., Feldman, Y. D., Ishai, P. B., & Launer, S. (2020) · Ear and Hearing · doi:10.1097/aud.0000000000000960 · Cited by 16
Busceti, C. L., Ferese, R., Bucci, D., Ryskalin, L., Gambardella, S., Madonna, M., Nicoletti, F., & Fornai, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122901 · Cited by 16
Delangre, E., Liu, J., Tolu, S., Maouche, K., Armanet, M., Cattan, P., Pommier, G., Bailbé, D., & Movassat, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04419-8 · Cited by 15
Animal Models of Cushing's Syndrome
Nishiyama, M., Iwasaki, Y., & Makino, S. (2022) · Endocrinology · doi:10.1210/endocr/bqac173 · Cited by 16
Approaching Gravity as a Continuum Using the Rat Partial Weight-Bearing Model
Mortreux, M., & Rosa‐Caldwell, M. E. (2020) · Life · doi:10.3390/life10100235 · Cited by 14
Daimon, M., KAMBA, A., Murakami, H., Mizushiri, S., Osonoi, S., Matsuki, K., Sato, E., Tanabe, J., Takayasu, S., Matsuhashi, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10815-y · Cited by 14
Rashed, E. R., El-Daly, M., elhalim, S. A. A., & El‐Ghazaly, M. A. (2016) · Radiation and Environmental Biophysics · doi:10.1007/s00411-016-0665-2 · Cited by 13
Nagata, M., Kimura, Y., Ishiwata, Y., Takahashi, H., & Yasuhara, M. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00195 · Cited by 13
Metadata
- Authors
- Rafacho, A., Ortsäter, H., Nadal, A., & Quesada, I.
- Affiliations
- Universitat de Miguel Hernández d'Elx (ES)
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2014-09-30
- Volume
- 223
- Issue
- 3
- Pages
- R49-R62
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2170071103
- Cited by
- 216
- References
- 124
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 21 · 2023: 14 · 2022: 19 · 2021: 18 · 2020: 18 · 2019: 27 · 2018: 27 · 2017: 16 · 2016: 22 · 2015: 15 · 2014: 1
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- Funders
- European Foundation for the Study of Diabetes
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (471397/2011-3)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- glucocorticoids, diabetogenic effect, glucose homeostasis, insulin resistance, beta-cell function, hyperinsulinemia, hyperglycemia, hyperglucagonaemia, islet hormones, somatostatin, amylin, ghrelin, osteocalcin, abdominal obesity, insulin signaling
- MeSH terms
- Animals, Blood Glucose, Diabetes Mellitus, Type 2, Glucocorticoids, Glucose, Homeostasis, Humans, Insulin Resistance, Islets of Langerhans, Models, Biological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review